Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vaccitech Plc ADR (VACC)

Vaccitech Plc ADR (VACC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vaccitech Plc ADR UNIT 6-10 ZEUS BUILDING RUTHERFORD AVENUE DIDCOT X0 OX11 0DF GBR

www.vaccitech.co.uk P: 44-18-6581-8808

Description:

Vaccitech plc is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Vaccitech plc is based in OXFORD, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 192,735
Enterprise Value, $K -1,655
Shares Outstanding, K 38,547
Annual Sales, $ 44,700 K
Annual Net Income, $ 5,340 K
Last Quarter Sales, $ 330 K
Last Quarter Net Income, $ -23,800 K
EBIT, $ -66,310 K
EBITDA, $ -61,990 K
60-Month Beta -0.40
% of Insider Shareholders 6.00%
% of Institutional Shareholders 26.13%
Float, K 36,234
% Float 94.00%
Short Volume Ratio 0.62

Growth:

1-Year Return 88.68%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.62 on 08/10/23
Next Earnings Date 11/09/23
Earnings Per Share ttm -1.43
EPS Growth vs. Prev Qtr -29.17%
EPS Growth vs. Prev Year -251.22%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VACC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -23.41%
Return-on-Assets % -20.85%
Profit Margin % 11.95%
Debt/Equity 0.00
Price/Sales 3.87
Price/Cash Flow 19.30
Price/Book 0.88
Book Value/Share 5.67
Interest Coverage 43.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar